Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol with ibuprofen/indomethacin for closure of persistent ductus arteriosus in premature infants
2018-000565-36Phase 2Terminated
- Sponsor
- University of Oulu
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of acetaminophen in patent ductus arteriosus (PDA), sponsored by University of Oulu. Primary endpoint: Ductal closure. Started Apr 2018; status: terminated.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on 2018-000565-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000565-36.